Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2010 2
2011 1
2012 1
2013 1
2015 2
2016 1
2017 4
2018 1
2019 4
2020 4
2021 9
2022 11
2023 7
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Periostin Is a Biomarker of Rheumatoid Arthritis-Associated Interstitial Lung Disease.
Matama G, Okamoto M, Fujimoto K, Johkoh T, Tominaga M, Mukae H, Sakamoto N, Komiya K, Umeki K, Komatsu M, Shimizu Y, Takahashi K, Tokisawa S, Zaizen Y, Matsuo N, Nouno T, Kaieda S, Ida H, Izuhara K, Hoshino T. Matama G, et al. Among authors: komatsu m. J Clin Med. 2023 Nov 15;12(22):7100. doi: 10.3390/jcm12227100. J Clin Med. 2023. PMID: 38002712 Free PMC article.
Clinical characteristics of immunoglobulin G4-positive interstitial pneumonia.
Komatsu M, Yamamoto H, Matsui S, Terasaki Y, Hebisawa A, Iwasawa T, Johkoh T, Baba T, Miyamoto A, Handa T, Tomii K, Waseda Y, Bando M, Ishii H, Miyazaki Y, Yoshizawa A, Takemura T, Kawabata Y, Ogura T. Komatsu M, et al. ERJ Open Res. 2021 Aug 31;7(3):00317-2021. doi: 10.1183/23120541.00317-2021. eCollection 2021 Jul. ERJ Open Res. 2021. PMID: 34476246 Free PMC article.
A prospective cohort study of periostin as a serum biomarker in patients with idiopathic pulmonary fibrosis treated with nintedanib.
Okamoto M, Fujimoto K, Johkoh T, Kawaguchi A, Mukae H, Sakamoto N, Ogura T, Ikeda S, Kondoh Y, Yamano Y, Komiya K, Umeki K, Nishikiori H, Tanino Y, Tsuda T, Arai N, Komatsu M, Sakamoto S, Yatera K, Inoue Y, Miyazaki Y, Hashimoto S, Shimizu Y, Hozumi H, Ohnishi H, Handa T, Hattori N, Kishaba T, Kato M, Inomata M, Ishii H, Hamada N, Konno S, Zaizen Y, Azuma A, Suda T, Izuhara K, Hoshino T. Okamoto M, et al. Among authors: komatsu m. Sci Rep. 2023 Dec 27;13(1):22977. doi: 10.1038/s41598-023-49180-4. Sci Rep. 2023. PMID: 38151520 Free PMC article.
Clinical Course of Eosinophilic Cellulitis.
Ozawa H, Kuwano K, Manabe S, Ishihara T, Komatsu M, Kobayashi T, Yanagi H, Oki M, Takagi A. Ozawa H, et al. Among authors: komatsu m. Tokai J Exp Clin Med. 2017 Dec 20;42(4):143-146. Tokai J Exp Clin Med. 2017. PMID: 29228410 Free article.
Rechallenge of afatinib for EGFR-mutated non-small cell lung cancer previously treated with osimertinib: a multicenter phase II trial protocol (REAL study).
Araki T, Kanda S, Komatsu M, Sonehara K, Tateishi K, Takada M, Kato A, Yamamoto M, Nishie K, Hama M, Agatsuma T, Kakizaki Y, Yoshiike F, Matsuo A, Chiaki T, Samizo K, Takagi Y, Yamaura M, Hanaoka M, Koizumi T. Araki T, et al. Among authors: komatsu m. Transl Lung Cancer Res. 2023 Jun 30;12(6):1320-1327. doi: 10.21037/tlcr-23-12. Epub 2023 Jun 15. Transl Lung Cancer Res. 2023. PMID: 37425417 Free PMC article.
Left Main Bronchial Stenosis due to Schwannoma.
Komatsu M, Hachiya T, Takahashi H, Yoshida K. Komatsu M, et al. Intern Med. 2018 Jul 1;57(13):1947-1948. doi: 10.2169/internalmedicine.0224-17. Epub 2018 Feb 28. Intern Med. 2018. PMID: 29491291 Free PMC article. No abstract available.
EGFR-TKI rechallenge in patients with EGFR-mutated non-small-cell lung cancer who progressed after first-line osimertinib treatment: A multicenter retrospective observational study.
Araki T, Kanda S, Obara M, Agatsuma T, Kakizaki Y, Hama M, Yamamoto H, Takada M, Yamamoto M, Matsuo A, Kondo D, Komatsu M, Sonehara K, Tateishi K, Hanaoka M, Koizumi T. Araki T, et al. Among authors: komatsu m. Respir Investig. 2024 Mar;62(2):262-268. doi: 10.1016/j.resinv.2024.01.002. Epub 2024 Jan 20. Respir Investig. 2024. PMID: 38245931 Free article.
Respiratory lesions in IgG4-related disease: classification using 2019 American College of Rheumatology/European League Against Rheumatism criteria.
Komatsu M, Yamamoto H, Matsui S, Terasaki Y, Hebisawa A, Iwasawa T, Johkoh T, Baba T, Miyamoto A, Handa T, Tomii K, Waseda Y, Bando M, Ishii H, Miyazaki Y, Yoshizawa A, Takemura T, Kawabata Y, Hanaoka M, Ogura T; Tokyo Diffuse Lung Disease Study Group. Komatsu M, et al. ERJ Open Res. 2022 Sep 12;8(3):00120-2022. doi: 10.1183/23120541.00120-2022. eCollection 2022 Jul. ERJ Open Res. 2022. PMID: 36105152 Free PMC article.
Prognostic implication of IgG4 and IgG1-positive cell infiltration in the lung in patients with idiopathic interstitial pneumonia.
Komatsu M, Yamamoto H, Uehara T, Kobayashi Y, Hozumi H, Fujisawa T, Miyamoto A, Kishaba T, Kunishima F, Okamoto M, Kitamura H, Iwasawa T, Matsushita S, Terasaki Y, Kunugi S, Ushiki A, Yasuo M, Suda T, Hanaoka M. Komatsu M, et al. Sci Rep. 2022 Jun 3;12(1):9303. doi: 10.1038/s41598-022-13333-8. Sci Rep. 2022. PMID: 35661786 Free PMC article.
54 results